Top 10 shareholders as of March 31, 2022
Name |
Number of shares |
Ownership in pct |
Redmile Group, LLC |
5 415 663 |
12.2% |
Fjärde AP-Fonden (AP 4) |
2 207 397 |
4.9% |
Nexttobe AB |
2 155 379 |
4.8% |
Invesco Advisers, Inc. |
1 973 931 |
4.4% |
Olausson, Thomas |
1 820 500 |
4.1% |
Tredje AP-Fonden (AP 3) |
1 389 650 |
3.1% |
Handelsbanken Asset Management (Sweden) |
1 369 877 |
3.1% |
Försäkrings AB Avanza Pension |
1 314 165 |
3.0% |
The Vanguard Group, Inc. |
1 223 839 |
2.8% |
Schroder Investment Management, LTD |
888 132 |
2.0% |
Others |
24 714 919 |
55.6% |
Outstanding shares in total |
44,473,452 |
100.0% |
Source: IHS Markit/IPREO compiled and processed data from various sources, including Euroclear, Morningstar, Factset
and the Swedish Financial Supervisory Authority (Finansinspektionen).
Hansa Biopharma had approximately 18,000 shareholders as of March 31, 2022.